European Companies Search Engine
UK funding (£733,394): Terahertz real-time release testing for pharmaceutical products Ukri 1 Feb 2018 UK Research and Innovation, United Kingdom
Overview
Text
Terahertz real-time release testing for pharmaceutical products
| Abstract | The project will develop a new, rapid and non-destructive test instrument for predicting tablet efficacy and performance, based on direct measurements of tablet porosity using terahertz light. In so doing, we expect to contribute to manufacturing efficiency improvements in production of advanced solid dose medicines. Our technology will initially be marketed as a test which can work alongside existing methods (dissolution/disintegration and hardness testing) to improve tablet quality during the design process. The ultimate goal is to act as a real-time, in-line test and feedback mechanism as the industry moves towards Continuous Manufacturing. |
| Category | Collaborative R&D |
| Reference | 104196 |
| Status | Closed |
| Funded period start | 01/02/2018 |
| Funded period end | 31/01/2020 |
| Funded value | £733,394.00 |
| Source | https://gtr.ukri.org/projects?ref=104196 |
Participating Organisations
| TERAVIEW LIMITED |
£327,705.00 |
| GLAXOSMITHKLINE PLC |
£20,206.00 |
| UNIVERSITY OF CAMBRIDGE |
£225,317.00 |
| HUXLEY BERTRAM ENGINEERING LIMITED |
£160,166.00 |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Teraview Ltd., Cambridge.